<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Longevity AGING</title><link>https://www.patfun.com/aging/en</link><description>Start with a disease or technology you care about, then see what is available now, what is still being studied and where caution is needed.</description><language>en</language><item><title>The United States expanded an accelerated approval in HER2-mutated lung cancer</title><link>https://www.patfun.com/aging/en/updates/aging-event-sevabertinib-2026-09-09</link><guid isPermaLink="true">https://www.patfun.com/aging/en/updates/aging-event-sevabertinib-2026-09-09</guid><pubDate>Wed, 09 Sep 2026 00:00:00 GMT</pubDate><description>This is a product-, mutation-, disease-stage- and region-specific regulatory change, not proof of approval in China or suitability for an individual.</description></item></channel></rss>
